NR3C1 and rheumatoid arthritis: Although GCs are used to ameliorate the symptoms of rheumatoid arthritis (RA) since the 1950s, there are still surprises concerning the mode of action of GCs, their activating enzymes 11β-HSD1 and the GR requirement in distinct cell types.